About Imprint

Imprint's goal is to provide technologies which transform the performance of injectable therapeutics.  Our clients know that with the help of our technology they can develop products that perform beyond those of their competitors.

The company was founded by Dr Kevin Maynard and Peter Crocker, who each have over 20 years’ experience in the pharmaceutical industry. They have assembled a world-class team of engineers, formulation scientists, regulatory and clinical personnel with proven ability to deliver products to market. Using this depth of experience, Imprint has developed unique drug delivery technologies for complex injectable formulations.

The company is backed by a highly regarded team of business angels led by the Oxfordshire Investment Opportunity Network (OION), Oxford Innovation and The Oxford Trust. Imprint is supported by the National Endowment for Science, Technology and the Arts (NESTA) and the UK Government's SMART award scheme for innovative technologies.